Federated Hermes, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $2,172 - $3,486	-319 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.14 - $8.31 $939 - $1,271	153 Added 92.17%	319 $2,000
Q4 2020 Feb 12, 2021	BUY	$4.58 - $7.14 $73 - $114	16 Added 10.67%	166 $1,000
Q3 2020 Nov 12, 2020	SELL	$4.19 - $6.69 $147,814 - $236,009	-35,278 Reduced 99.58%	150 $1,000
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $669,589 - $999,069	35,428	35,428 $889,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.